The Biotech Growth Trust PLC - Overview
Investment Policy
The Company’s policy is to invest in emerging biotechnology companies generally with a market cap of less than US$3bn that have undergone an IPO but are, as yet, unprofitable. They will typically be focused on drug research and development, with their valuations driven by pipeline developments, clinical trial results and partnerships.
Investment Objective
The Biotech Growth Trust PLC seeks capital appreciation through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies.
- Launch Date: June 1997
- Benchmark: NASDAQ Biotechnology Index (Sterling adjusted)
- Registered Office: One Wood Street, London EC2V 7WS
- Company Registration No. 3376377 (Registered in England)
- SEDOL: 0038551
- Epic: BIOG
Request Information:
To request emailed copies of monthly fact sheets and other relevant information, please register below and indicate if you are a retail or professional investor:
Investment Manager: OrbiMed Capital LLC
- Contact
- |
- © Frostrow Capital
- website design by Atelier Studios
